Skip to main content
. 2023 Apr 14;10:1135541. doi: 10.3389/fmed.2023.1135541

Figure 4.

Figure 4

Stage wise diagrammatic illustration of the production of monoclonal antibodies via the popular Hybridoma Technology for usage in the case of a broad spectrum of human infectious microbial diseases (Bacterial and Fungal).